{"schema_version":"1","generated_at":"2026-11-01T20:10:59.149Z","data_as_of":"2026-10-27","url":"https://www.findmykol.com/kol/raymond-cho","json_url":"https://www.findmykol.com/kol/raymond-cho/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"raymond-cho","name":"Raymond Cho","credential":"MD","title":"Professor, Dermatology","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"institution":"University of California, San Francisco","institution_url":"https://www.findmykol.com/institution/university-of-california-san-francisco","city":"San Francisco","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1790999175"},"summary":"Raymond Cho is Professor, Dermatology at University of California, San Francisco. ClinicalTrials.gov lists 8 registered studies with this person as an investigator.","overview":{"text":"Raymond Cho, M.D., PH.D., is Professor, Dermatology at University of California, San Francisco. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 16 companies, 4 NIH-funded awards (2000–2026).","bullets":["Top research focus: Atopic Dermatitis / Eczema","8 registered trials on ClinicalTrials.gov","Open Payments reporting from 16 companies"],"generated_at":"2026-11-01"},"focus":{"indications":[{"label":"Psoriasis / Psoriatic Arthritis","therapeutic_area":"Rheumatology/Immunology","trials":5,"topics":0,"strength":15},{"label":"Schizophrenia","therapeutic_area":"Psychiatry","trials":2,"topics":0,"strength":6},{"label":"Psychotic Disorders","therapeutic_area":"Psychiatry","trials":2,"topics":0,"strength":6},{"label":"Atopic Dermatitis / Eczema","therapeutic_area":"Dermatology","trials":2,"topics":0,"strength":6}],"research_topics":["Atopic Dermatitis / Eczema"],"drugs_studied":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Dupixent","generic":"Dupilumab","trials":0,"payments":12,"publications":0,"mentions":12},{"name":"Opzelura","generic":"Ruxolitinib","trials":0,"payments":5,"publications":0,"mentions":5},{"name":"Sotyktu","generic":"Deucravacitinib","trials":0,"payments":4,"publications":0,"mentions":4}]},"works_with":{"total":16,"shown":3,"withheld":13,"rows":[{"name":"Regeneron Pharmaceuticals, Inc.","trials":0,"payments":10,"mentions":10},{"name":"E.R. Squibb & Sons, L.L.C.","trials":0,"payments":7,"mentions":7},{"name":"Genzyme Corporation","trials":0,"payments":7,"mentions":7}]}},"scholarship":{"h_index":0,"pubmed_count":0,"latest_activity_year":2026,"source":"works"},"trials":{"count":8,"shown":3,"withheld":5,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07352566","title":"Utilization of a Microdevice for Psoriasis and Atopic Dermatitis","phase":"PHASE4","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"University of California, San Francisco","source_url":"https://clinicaltrials.gov/study/NCT07352566","trial_url":"https://www.findmykol.com/trial/NCT07352566"},{"nct":"NCT05858645","title":"Correction of Psoriatic T Cell Signatures by Deucravacitinib","phase":"PHASE4","status":"RECRUITING","role":"Investigator","sponsor":"University of California, San Francisco","source_url":"https://clinicaltrials.gov/study/NCT05858645","trial_url":"https://www.findmykol.com/trial/NCT05858645"},{"nct":"NCT05858632","title":"Immune Spatial Features of Guselkumab Cutaneous Response","phase":"PHASE4","status":"RECRUITING","role":"Investigator","sponsor":"University of California, San Francisco","source_url":"https://clinicaltrials.gov/study/NCT05858632","trial_url":"https://www.findmykol.com/trial/NCT05858632"}],"source":"trials"},"payments":{"company_count":16,"program_years":{"first":2021,"last":2025},"rows_total":27,"shown":3,"withheld":24,"rows":[{"payer":"Janssen Scientific Affairs, LLC","program_year":2025,"amount_usd":1930,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1790999175"},{"payer":"Galderma Laboratories, L.P.","program_year":2025,"amount_usd":220.03,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1790999175"},{"payer":"GENZYME CORPORATION","program_year":2025,"amount_usd":189.59,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1790999175"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1790999175","source":"payments"},"prescribing":{"data_year":2024,"areas_total":9,"areas_shown":3,"areas":[{"area":"Dermatology","share_pct":31.2,"classes_total":4,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":12.7,"drugs":[{"name":"Triamcinolone Acetonide","share_pct":100}],"max_beneficiaries":55},{"class":"Interleukin-4 Receptor alpha Antagonist","setting":"prescribed","share_pct":8.1,"drugs":[{"name":"Dupixent Pen","share_pct":66},{"name":"Dupixent Syringe","share_pct":34}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":17.8,"classes_total":4,"classes":[{"class":"Nucleoside Metabolic Inhibitor","setting":"prescribed","share_pct":10.2,"drugs":[{"name":"Fluorouracil","share_pct":100}],"max_beneficiaries":48},{"class":"Folate Analog Metabolic Inhibitor","setting":"prescribed","share_pct":3.4,"drugs":[{"name":"Methotrexate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":16.6,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":9.3,"drugs":[{"name":"Fluocinonide","share_pct":100}],"max_beneficiaries":34},{"class":"Arteriolar Vasodilator","setting":"prescribed","share_pct":7.3,"drugs":[{"name":"Minoxidil","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":4,"fiscal_years":{"first":2000,"last":2026},"rows_total":21,"shown":3,"withheld":18,"rows":[{"project":"R01AR084006","title":"Defining and treating genetic abnormalities in psoriasis/atopic dermatitis-overlap dermatoses","fiscal_year":2026,"amount_usd":545401,"organization":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","source_url":"https://reporter.nih.gov/quickSearch/R01AR084006"},{"project":"R01AR084006","title":"Defining and treating genetic abnormalities in psoriasis/atopic dermatitis-overlap dermatoses","fiscal_year":2025,"amount_usd":628968,"organization":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","source_url":"https://reporter.nih.gov/quickSearch/R01AR084006"},{"project":"R56AR082484","title":"Investigating single-T cell atopic gene networks in Asian and Hispanic genetic backgrounds","fiscal_year":2024,"amount_usd":343904,"organization":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","source_url":"https://reporter.nih.gov/quickSearch/R56AR082484"}],"source":"grants"},"publications":{"total":0,"shown":0,"withheld":0,"recent":[],"source":"works"},"recognition":{"education":{"total":3,"shown":3,"rows":[{"value":"M.D., Stanford University School of Medicine, 2005","source_url":"https://profiles.ucsf.edu/raymond.cho","status":"verified","collected_at":"2026-11-01"},{"value":"Ph.D., Stanford University, Department of Genetics, 2003","source_url":"https://profiles.ucsf.edu/raymond.cho","status":"verified","collected_at":"2026-11-01"},{"value":"Board certified in Dermatology, American Board of Dermatology","source_url":"https://www.ucsfhealth.org/providers/raymond-cho","status":"verified","collected_at":"2026-11-01"}]},"awards":{"total":8,"shown":3,"rows":[{"value":"IPOKRaTES Foundation 2025 - 2026 Visiting Lecturer, Innsbruck and Linz, Austria","source_url":"https://profiles.ucsf.edu/raymond.cho","status":"verified","collected_at":"2026-11-01"},{"value":"LEO Foundation 2020 - 2024 Foundation Grant","source_url":"https://profiles.ucsf.edu/raymond.cho","status":"verified","collected_at":"2026-11-01"},{"value":"Epidermolysis Bullosa Research Foundation Award (2018-2020)","source_url":"https://profiles.ucsf.edu/raymond.cho","status":"verified","collected_at":"2026-11-01"}]},"media":{"total":10,"shown":3,"rows":[{"value":"Brachioradial pruritus, New York Times (11/29/2024)","source_url":"https://profiles.ucsf.edu/raymond.cho","status":"verified","collected_at":"2026-11-01"},{"value":"Spatial insights into IL-23 blockade (01/29/2024)","source_url":"https://profiles.ucsf.edu/raymond.cho","status":"verified","collected_at":"2026-11-01"},{"value":"A more precise way to knock out skin rashes (04/26/2022)","source_url":"https://profiles.ucsf.edu/raymond.cho","status":"verified","collected_at":"2026-11-01"}]}},"similar":[{"name":"Talmadge King","slug":"talmadge-king","institution":"University of California, San Francisco","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/talmadge-king","json_url":"https://www.findmykol.com/kol/talmadge-king/profile.json"},{"name":"Adil Daud","slug":"adil-daud","institution":"University of California, San Francisco","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/adil-daud","json_url":"https://www.findmykol.com/kol/adil-daud/profile.json"},{"name":"Emmanuelle Waubant","slug":"emmanuelle-waubant","institution":"University of California, San Francisco","specialty":"Neurology","url":"https://www.findmykol.com/kol/emmanuelle-waubant","json_url":"https://www.findmykol.com/kol/emmanuelle-waubant/profile.json"},{"name":"Peter Ganz","slug":"peter-ganz","institution":"University of California, San Francisco","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/peter-ganz","json_url":"https://www.findmykol.com/kol/peter-ganz/profile.json"},{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Heidi Kong","slug":"heidi-kong","institution":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/heidi-kong","json_url":"https://www.findmykol.com/kol/heidi-kong/profile.json"},{"name":"Jon Hanifin","slug":"jon-hanifin","institution":"Oregon Health & Science University (OHSU)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/jon-hanifin","json_url":"https://www.findmykol.com/kol/jon-hanifin/profile.json"},{"name":"Victoria Werth","slug":"victoria-werth","institution":"Perelman School of Medicine at the University of Pennsylvania","specialty":"Dermatology","url":"https://www.findmykol.com/kol/victoria-werth","json_url":"https://www.findmykol.com/kol/victoria-werth/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":5,"payments":24,"funding":18}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-01"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-01"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-11-01"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-11-01"}},"methodology_url":"https://www.findmykol.com/about#methodology"}